ANURAS1,230.00

Anupam Rasayan India Ltd.

· Chemicals
₹ CrorePeersAETHERPIINDATULSHKBAYERCROPSWANCORPCAMLINFINECLEANMcap ₹14,003 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ANURAS
FY26
AETHER
FY26
PIIND
FY26
ATUL
FY26
Peer
Median
Valuation — at last close
P/E81.51×99.40×27.03×27.49×27.49× +196%
P/B3.02×8.89×3.18×2.96×3.18× -5%
EV/EBITDA29.39×61.22×20.24×16.57×20.24× +45%
Market Cap₹14,003 Cr₹21,826 Cr₹35,766 Cr₹18,636 Cr₹21,826 Cr -36%
Growth
Revenue CAGR 3Y13.87%21.23%1.13%4.95%4.95% +180%
Revenue CAGR 5Y23.88%7.96%10.95%9.46% +153%
Net Income CAGR 3Y0.82%18.94%2.42%10.81%10.81% -92%
Revenue YoY (latest Q)34.82%27.49%-10.43%25.03%25.03% +39%
Net Income YoY (latest Q)5.69%33.45%-38.95%91.85%33.45% -83%
Profitability
EBITDA Margin22.19%31.34%25.32%16.43%25.32% -12%
Net Income Margin9.39%18.92%19.67%10.99%18.92% -50%
Return on Common Equity3.67%8.94%11.58%10.77%10.77% -66%
Return on Capital Employed7.13%11.68%11.08%10.45%11.08% -36%
Return on Assets2.77%6.86%9.82%8.73%8.73% -68%
Credit & Quality
Total Debt/Equity0.39×0.18×0.02×0.03×0.03× +1200%
Interest Coverage2.59×16.43×78.84×40.66×40.66× -94%
Scale — latest FY
Revenue / Total Income₹2,365 Cr₹1,160 Cr₹6,714 Cr₹6,274 Cr₹6,274 Cr -62%
Net Income₹222 Cr₹219 Cr₹1,321 Cr₹689 Cr₹689 Cr -68%
Total Assets₹8,013 Cr₹3,201 Cr₹13,444 Cr₹7,900 Cr₹7,900 Cr +1%
EPS₹15.09₹16.55₹87.06₹230.25₹87.06 -83%
Book Value per Share₹406.68₹185.1₹738.85₹2,138.77₹738.85 -45%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.